Blueprint Medicines to Report Second Quarter 2023 Financial Results on Wednesday, August 2, 2023
- Investors can access the live conference call and webcast to stay updated on Blueprint Medicines' financial performance and corporate developments.
- No negative takes available.
To access the live conference call, please dial 833-470-1428 (domestic) or 404-975-4839 (international), and refer to conference ID 669158. A webcast of the call will also be available under "Events and Presentations" in the Investors & Media section of the Blueprint Medicines website at http://ir.blueprintmedicines.com/. The archived webcast will be available on Blueprint Medicines' website approximately two hours after the conference call and will be available for 30 days following the call.
About Blueprint Medicines
Blueprint Medicines is a global precision therapy company that invents life-changing therapies for people with cancer and blood disorders. Applying an approach that is both precise and agile, we create medicines that selectively target genetic drivers, with the goal of staying one step ahead across stages of disease. Since 2011, we have leveraged our research platform, including expertise in molecular targeting and world-class drug design capabilities, to rapidly and reproducibly translate science into a broad pipeline of precision therapies. Today, we are delivering our approved medicines to patients in
View original content to download multimedia:https://www.prnewswire.com/news-releases/blueprint-medicines-to-report-second-quarter-2023-financial-results-on-wednesday-august-2-2023-301878911.html
SOURCE Blueprint Medicines Corporation
FAQ
When will Blueprint Medicines host the conference call?
What will be discussed during the conference call?
How can investors access the conference call?
Where can the webcast of the call be found?
